🇮🇳IN
Sign In
CO

CORONA

NSE

CORONA Remedies Limited

₹2,271.60

+116.40(+5.40%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into CORONA. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

CORONA exposure summary

CORONA Remedies Limited reports a single business segment, PHARMACEUTICALS. CORONA Remedies Limited is a constituent of 2 indices. 1 exchange-traded fund holds the stock.

Index memberships2
ETFs holding1

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer